WENDELL SEYMOUR: Open Payments
NPI 1467071746 · MANVEL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$160 in 7 payments from 5 companies in 2025. Trend: 2023 $78 · 2024 $584 · 2025 $160
Food & beverage: $160
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
Products named: REXULTI, XHANCE, KESIMPTA, PAXLOVID, NUZYRA.
Industry payments across TX — which companies pay providers there.
